U.S. Creatine Industry "Materially Injured" By Chinese Importation - ITC
This article was originally published in The Tan Sheet
Executive Summary
Creatine imported from Chinese companies selling the dietary supplement ingredient below fair market prices poses a material threat to U.S. creatine producers, the U.S. International Trade Commission determines in an April preliminary investigation report.
You may also be interested in...
Chinese Bulk Aspirin Sales Below Fair Value In U.S. -ITA
Bulk aspirin imported from the People's Republic of China (PRC) is being, or is likely to be, sold in the U.S. at less than fair value margins ranging up to 144%, the International Trade Administration says in a preliminary determination published in the Federal Register Jan. 3.
Chinese Bulk Aspirin Sales Below Fair Value In U.S. -ITA
Bulk aspirin imported from the People's Republic of China (PRC) is being, or is likely to be, sold in the U.S. at less than fair value margins ranging up to 144%, the International Trade Administration says in a preliminary determination published in the Federal Register Jan. 3.
Chinese Bulk Aspirin Sales Below Fair Value In U.S. -ITA
Bulk aspirin imported from the People's Republic of China (PRC) is being, or is likely to be, sold in the U.S. at less than fair value margins ranging up to 144%, the International Trade Administration says in a preliminary determination published in the Federal Register Jan. 3.